These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 32788543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
    Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y, Uraoka T.
    Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and potential usefulness of sequential intracoronary acetylcholine and ergonovine administration for spasm provocation testing.
    Kinoshita Y, Saito Y, Kikuta Y, Sato K, Taniguchi M, Goto K, Takebayashi H, Haruta S, Kobayashi Y.
    Ther Adv Cardiovasc Dis; 2024 Dec; 18():17539447241233168. PubMed ID: 38396350
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
    Sueda S.
    Heart Vessels; 2020 Oct; 35(10):1368-1377. PubMed ID: 32350639
    [Abstract] [Full Text] [Related]

  • 6. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.
    Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H.
    Heart Vessels; 2016 Feb; 31(2):137-42. PubMed ID: 25366987
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
    Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H.
    Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
    [Abstract] [Full Text] [Related]

  • 9. Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
    Sueda S, Kohno H, Miyoshi T, Sakaue T, Sasaki Y, Habara H.
    Heart Vessels; 2015 Nov; 30(6):771-8. PubMed ID: 25179297
    [Abstract] [Full Text] [Related]

  • 10. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
    Sueda S, Miyoshi T, Sasaki Y, Sakaue T, Habara H, Kohno H.
    Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sex-related Differences in Patients with Positive Coronary Spasm as Identified by Acetylcholine Testing.
    Sueda S, Sakaue T.
    Intern Med; 2021 Aug 01; 60(15):2357-2365. PubMed ID: 33583899
    [Abstract] [Full Text] [Related]

  • 13. Safety and Usefulness of Intracoronary Acetylcholine 200 μg Into the Left Coronary Artery as Vasoreactivity Testing: Comparisons With Intracoronary Acetylcholine Maximum 100 μg.
    Sueda S, Hayashi Y, Ono H, Sakaue T, Ikeda S.
    Clin Cardiol; 2024 Oct 01; 47(10):e70001. PubMed ID: 39355891
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.
    Saito Y, Kitahara H, Shoji T, Tokimasa S, Nakayama T, Sugimoto K, Fujimoto Y, Kobayashi Y.
    Heart Vessels; 2017 Jun 01; 32(6):685-689. PubMed ID: 27873006
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Complete definite positive spasm on acetylcholine spasm provocation tests: comparison of clinical positive spasm.
    Sueda S, Miyoshi T, Sasaki Y, Ohshima K, Sakaue T, Habara H, Kohno H.
    Heart Vessels; 2016 Feb 01; 31(2):143-51. PubMed ID: 25366988
    [Abstract] [Full Text] [Related]

  • 18. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.
    Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S, Hill S, Schäufele T, Mahrholdt H, Kaski JC, Sechtem U.
    Circulation; 2014 Apr 29; 129(17):1723-30. PubMed ID: 24573349
    [Abstract] [Full Text] [Related]

  • 19. Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine.
    Sueda S, Kohno H, Fukuda H, Inoue K, Suzuki J, Watanabe K, Ochi T, Uraoka T.
    Coron Artery Dis; 2002 Jun 29; 13(4):231-6. PubMed ID: 12193850
    [Abstract] [Full Text] [Related]

  • 20. Overview of the Acetylcholine Spasm Provocation Test.
    Sueda S, Kohno H, Ochi T, Uraoka T.
    Clin Cardiol; 2015 Jul 29; 38(7):430-8. PubMed ID: 26175183
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.